Antimony Trisulfide Bos Taurus Hypothalamus Fucus

證據等級: L5

預測適應症: 0 個

Multi-Ingredient Compound (Antimony Trisulfide / Fucus Vesiculosus / Thyroid): Insufficient Evidence for Repurposing Evaluation

One-Sentence Summary

This is a complex multi-ingredient preparation comprising seven components — including homeopathic minerals, bovine glandulars, botanical extracts, and a thyroid fraction — with no established approved indication on record. The TxGNN model was unable to generate any repurposing prediction for this compound, most likely because the multi-ingredient composition could not be mapped to a single DrugBank entity. As a result, no clinical trial or literature evidence can be linked to a predicted new indication at this time.

Quick Overview

Item	Content
Original Indication	None on record
Predicted New Indication	None (TxGNN prediction not available)
TxGNN Prediction Score	N/A
Evidence Level	L5 — model prediction unavailable; no supporting studies
US Market Status	Not marketed
Number of NDAs	0
Recommended Decision	Hold

Why is This Prediction Reasonable?

Detailed mechanism of action data is not available, and no DrugBank ID could be assigned to this compound. The seven ingredients span multiple pharmacological categories:

Fucus vesiculosus (bladderwrack) contains iodine and has historically been associated with thyroid modulation.
Thyroid, unspecified is a crude glandular extract sometimes used in traditional compounding.
Phytolacca americana root carries immune-modulatory and anti-inflammatory properties in herbal medicine literature, but its clinical evidence base is sparse.
Semecarpus anacardium juice is an Ayurvedic botanical with reported anti-tumour and anti-inflammatory activity in preclinical models.
Antimony trisulfide and sodium sulfate are inorganic compounds with roots in homeopathic practice.
Bos taurus hypothalamus is a bovine glandular used in integrative medicine formulations.

Because the compound is a mixture of chemically and pharmacologically heterogeneous agents, the TxGNN knowledge-graph model — which operates on single-entity DrugBank nodes — cannot assign a unified drug representation and therefore produces no prediction. Without a prediction, there is no anchor disease to evaluate.

Clinical Trial Evidence

Currently no related clinical trials registered.

Literature Evidence

Currently no related literature available for the compound as a whole. Individual ingredients have scattered preclinical reports, but these cannot be attributed to this multi-ingredient formulation as a unit.

US Market Information

This compound holds no NDA or any US market authorization. No product licensing records were retrieved.

Safety Considerations

Please refer to the package insert for safety information.

For individual ingredient safety considerations:

Phytolacca americana (pokeweed) is recognized as toxic in high doses; roots contain phytolaccatoxin and phytolaccigenin.
Semecarpus anacardium juice contains urushiol-type compounds and may cause contact sensitization.
Thyroid glandular extracts carry risk of hyperthyroidism in sensitive patients.

No formal drug–drug interaction data is available for this combination.

Conclusion and Next Steps

Decision: Hold

Rationale: The compound cannot be processed by the TxGNN repurposing pipeline because it lacks a DrugBank identifier and comprises seven pharmacologically disparate ingredients. Without a prediction, there is no candidate indication to evaluate, and no safety dossier exists to support a go/no-go assessment.

To proceed, the following is needed:

Clarify whether this is a registered homeopathic or naturopathic product — if so, retrieve the official product monograph and indication text from the originating regulatory body (e.g., FDA OTC homeopathic monograph, DSHEA supplement filing)
Decompose the formulation into individual active ingredients and run TxGNN predictions separately for each mappable component (e.g., Fucus vesiculosus, Phytolacca americana)
Obtain a DrugBank ID or equivalent ontology identifier for at least the botanically or pharmacologically dominant component to enable knowledge-graph traversal
Conduct a safety review for each ingredient individually, with particular attention to pokeweed toxicity thresholds and iodine-induced thyroid effects
Assess whether this compound meets the threshold for drug vs. dietary supplement classification before investing further repurposing resources
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.